JP Morgan Call 25 MRO 20.06.2025/ DE000JK24387 /
28/05/2024 09:53:48 | Var.- | Denaro22:00:41 | Lettera22:00:41 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.500EUR | - | - Quantità in denaro: - |
- Quantità in lettera: - |
Marathon Oil Corp | 25.00 - | 20/06/2025 | Call |
GlobeNewswire
20:01
Dr. Ralph Thomas Champions Global Innovation with AGI54 Rollout Across 170 Resorts in Six Countries
GlobeNewswire
20:00
Troy de Haas Joins Global Executive Search Firm ZRG as Managing Director for Asia-Pacific
GlobeNewswire
20:00
Planet Fitness Franchise Groups Launch Fundraising Campaign for St. Jude Children’s Research Hospita...
GlobeNewswire
20:00
New SFI 2025-2030 Strategic Direction Engages Communities in Forests for the Future
GlobeNewswire
19:53
Alabama Farmers Gather to Demand Change in the Farm Bill During Event Held in Guntersville
GlobeNewswire
19:53
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
GlobeNewswire
19:49
SECU Awards Statewide Scholarships to 234 Youth Members for Summer Camp Adventures
GlobeNewswire
19:45
ZSFab Announces First U.S. Clinical Use of InterConnect™ 3D Printed Ti Lumbar Interbody System
GlobeNewswire
19:30
Quell Therapeutics Advances QEL-001, its Multi-modular Engineered CAR-Treg Cell Therapy, into Effica...
GlobeNewswire
19:25
CosMedical Technologies® Unveils Revitalize + Restore Microbiome Shampoo: A Revolutionary Solution f...
GlobeNewswire
19:24
ROSEN, A LEADING LAW FIRM, Encourages Direct Digital Holdings, Inc. Investors to Secure Counsel Befo...
GlobeNewswire
19:02
SOND FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sonder Holdings Inc. Investors to S...
GlobeNewswire
19:00
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology ...